Hegenbart, U., Bochtler, T., Benner, A., Kimmich, C., Kristen, A., Beimler, J., . . . Schönland, S. (2017). Lenalidomide/melphalan/dexamethasone in newly diagnosed patients with immunoglobulin light chain amyloidosis: Results of a prospective phase 2 study with long-term follow up. Haematologica, 102(8), . https://doi.org/10.3324/haematol.2016.163246
Chicago-Zitierstil (17. Ausg.)Hegenbart, Ute, et al. "Lenalidomide/melphalan/dexamethasone in Newly Diagnosed Patients with Immunoglobulin Light Chain Amyloidosis: Results of a Prospective Phase 2 Study with Long-term Follow Up." Haematologica 102, no. 8 (2017). https://doi.org/10.3324/haematol.2016.163246.
MLA-Zitierstil (9. Ausg.)Hegenbart, Ute, et al. "Lenalidomide/melphalan/dexamethasone in Newly Diagnosed Patients with Immunoglobulin Light Chain Amyloidosis: Results of a Prospective Phase 2 Study with Long-term Follow Up." Haematologica, vol. 102, no. 8, 2017, https://doi.org/10.3324/haematol.2016.163246.